Sanofi chief on new partnership with OpenAI for AI-driven drug development

Sanofi – Partner Spotlight: Owkin and Sanofi Embrace the “Golden Era” of Precision Medicine with AIПодробнее

Sanofi – Partner Spotlight: AQEMIA and Sanofi Harness Generative AI and Deep Physics to Power R&DПодробнее

ARTIFICIAL INTELLIGENCE & BIG DATA FOR HEALTHCARE- DR SHAMEER KHADER-EXEC DIR: SANOFIПодробнее

Opportunities with AI Driven Drug DiscoveryПодробнее

AI in Healthcare: Uncovering Future Breakthroughs with DeepMirror and Dr. Max JakobsПодробнее

"AI is inverting the pyramid..." | Paul Hudson, CEO at SanofiПодробнее

Sanofi CEO on AI's Impact, Lung Disease Drug ClearanceПодробнее

Sanofi CEO on using AI to support drug trialsПодробнее

How AI is accelerating drug discovery - Nature's Building Blocks | BBC StoryWorksПодробнее

This is the 1st drug designed by generative AI in human clinical trialsПодробнее

Supercharging Drug Discovery with AI and Bioinformatics #bioinformatics #ai #ml #drugdiscoveryПодробнее

CEO Paul Hudson on Sanofi’s Bold New Strategy and “Snackable AI”Подробнее

Dave Johnson: Aligning culture & workforce into AI-driven approach to drug discovery | Domino's RevXПодробнее

Immunoprecise Antibodies (IPA) CEO Jennifer Bath - Commercial Launch of AI-Driven Drug Discovery APIПодробнее

Revolutionizing Drug Discovery: The Power of Generative Biology and AIПодробнее

Revolutionizing Drug Discovery with AI #ai #podcastПодробнее

Unlocking the potential of data & AI driven drug discovery and developmentПодробнее

Insilico Medicine - 10 Years of AI Drug Discovery InnovationПодробнее

Sanofi CEO Paul Hudson Talks AI for BioPharma | Bloomberg TalksПодробнее